Work

Effect of thymosin α1 on Immune response and organ function in acute aortic dissection surgery: PANDA II trial protocol

Year: 2025
Type: article
Study design: Study Protocol
Abstract: This multicenter randomized controlled trial evaluates the efficacy of thymosin alpha 1 (Tα1) supplementation in preventing organ dysfunction following acute type A aortic dissection (ATAAD) repair. Over 330 patients will be equally assigned to receive either Tα1 plus standard care or placebo with standard management. The primary endpoint involves calculating the difference in mean postoperative Sequential Organ Failure Assessment (SOFA) scores between groups, measured daily from postoperative days 7. By targeting post-operative immune system imbalance, this study aims to establish a novel therapeutic approach for reducing systemic inflammatory response syndrome (SIRS)-mediated organ injury and improving long-term outcomes in this high-risk population. Results will be disseminated through peer-reviewed publications and international conferences.Trial registration: ClinicalTrials.gov Registry (NCT05339529).
Authors: Hong Liu, Si-Chong Qian, Ying-Yuan Zhang, Cheng-Bin Tang, Hong-Hua Yue, Guo-Liang Fan, Xin Zhao, Yi-Yao Jiang, Fu-Hua Huang, Zhi-Hua Zeng, Wei Wang, Xu-Ran Lu, Xiao-Kang Luo, Xiang-Feng Bai, Xiang-Xiang Zheng, Peng Xie, Chao Ma, Sheng Zhao, Hong-Jia Zhang, On the behalf of China Additive Anti-inflammatory Actions for Aortopathy and Arteriopathy (5A) and PANDA Trial Investigators
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W4410358342
FWCI: 0.589
Cites: 33
Cited by: 1
Related to: 10